Pharmaceutical Sciences Asia

Faculty of Pharmacy, Mahidol University

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Pharmaceutical Sciences Asia is an open-access journal published by Faculty of Pharmacy, Mahidol University in Thailand, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 5 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Faculty of Pharmacy, Mahidol University
ISSN
2586-8195 · 2586-8470
Country
Thailand
Languages
english
Access
Open access
Articles in DOAJ
73
Declared review time
5 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2022-01-03
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
5 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

73

Most recent article

4 years ago

Average review time (journal-declared via DOAJ)

5weeks

Works in OpenAlex

393

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

12

i10-index

21

From OpenAlex open data (CC0).

Editorial & policy8
Last DOAJ review date
2022-01-03
Added to DOAJ
2022-01-03
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification6

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Pharmacy and materia medicaSocial Sciences: Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry

LCC codes

RM1-950RS1-441HD9665-9675

Subject areas

  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Natural Antidiabetic Agents Studies
  • Drug Solubulity and Delivery Systems
  • Natural Antidiabetic Agents Studies
  • Advanced Drug Delivery Systems
  • Essential Oils and Antimicrobial Activity
  • Analytical Methods in Pharmaceuticals
Show all subjects (50)
  • Analytical Methods in Pharmaceuticals
  • Essential Oils and Antimicrobial Activity
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Phytochemicals and Antioxidant Activities
  • Antibiotics Pharmacokinetics and Efficacy
  • Phytochemicals and Antioxidant Activities
  • Antibiotics Pharmacokinetics and Efficacy
  • Drug Solubulity and Delivery Systems
  • Advanced Drug Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Medicinal Plants and Neuroprotection
  • Analytical Chemistry and Chromatography
  • Bee Products Chemical Analysis
  • Medicinal Plants and Neuroprotection
  • Bee Products Chemical Analysis
  • Advancements in Transdermal Drug Delivery
  • Drug-Induced Hepatotoxicity and Protection
  • Medicinal Plant Research
  • Antibiotic Resistance in Bacteria
  • Analytical Chemistry and Chromatography
  • Pharmaceutical Economics and Policy
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical studies and practices
  • Phytochemistry and Biological Activities
  • Medicinal Plant Research
  • Antibiotic Resistance in Bacteria
  • Computational Drug Discovery Methods
  • Pharmaceutical Economics and Policy
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical studies and practices
  • Phytochemistry and Biological Activities
  • Natural product bioactivities and synthesis
  • Drug-Induced Hepatotoxicity and Protection
  • Medication Adherence and Compliance
  • Computational Drug Discovery Methods
  • Natural product bioactivities and synthesis
  • Medication Adherence and Compliance
  • Diabetes Treatment and Management
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes Treatment and Management
  • SARS-CoV-2 and COVID-19 Research

Keywords (DOAJ)

  • biopharmaceutical sciences
  • pharmaceutical sciences and technology
  • pharmaceutical chemistry and phytochemistry
  • clinical pharmacy and social administrative pharmacy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: